Henry Schein Inc

HSIC remains in a Stage 2 advancing uptrend with strong acceleration from the active Parabola pattern. However, price is extended above rising EMAs and in extreme overbought territory with visible exhaustion signals, so we defer execution. Awaiting a pullback into the rising 9/21 EMA zone aligns with our Free Cash Flow + Buybacks strategy for a more favorable entry.

• ↑U.S. dental merchandise revenue +5.6% YoY driven by DSO demand.
• ↑Targeting $200m annual operating income improvement via efficiency initiatives.
• ↓Q1 medical diagnostic revenue fell on respiratory test weakness.